Artificial Intelligence Predicts Next Session’s Price Change For KLAVENESS COMBINAT, DASSAULT AVIATION, AURES TECHNOLOGIES

(VIANEWS) – Today, the Innrs artificial intelligence algorithm suggests a high probability of discovering the approximate price for tomorrow of KLAVENESS COMBINAT KCC.OL, DASSAULT AVIATION AM.PA and others.

Via News will regularly fact-check this AI algorithm that aims to consistently predict the next session price and next week’s trend of financial assets.

Innrs provides A.I.-based statistical tools to help investors make decisions. The table below shows the financial assets predicting price, ordered by the highest expected accuracy.

Innrs officials say this tool helps investors make better-informed decisions, supposedly used alongside other relevant financial information and the specific trader strategy.

In the next session, Via News will report the finding on the algorithm precision.

1. KLAVENESS COMBINAT (KCC.OL)

Shares of KLAVENESS COMBINAT jumped 4.61% in from kr69.4 to kr72.60 at 23:50 EST on Wednesday, after five sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI is sliding 0.14% to kr1,243.59, after two consecutive sessions in a row of losses.

Klaveness Combination Carriers ASA owns and operates combination carriers in Norway, the Far East, the Middle East, Australia, Brazil, Gulf Coast of the United States, and North America. Its vessels transport caustic coda solution or clean petroleum products, floating fertilizer, molasses, and various types of dry cargo, as well as petroleum products, heavy liquid cargoes, and various types of dry bulk products, such as alumina, bauxite, Iron ore, salt, grains, and coal. Its fleet consists of 16 vessels. The company was incorporated in 2018 and is headquartered in Oslo, Norway. Klaveness Combination Carriers ASA is a subsidiary of Rederiaksjeselskapet Torvald Klaveness.

More news about KLAVENESS COMBINAT.

2. DASSAULT AVIATION (AM.PA)

Shares of DASSAULT AVIATION jumped 7% in from €151.4 to €162.00 at 23:50 EST on Wednesday, following the last session’s upward trend. CAC 40 is dropping 0.2% to €7,324.76, following the last session’s downward trend.

Dassault Aviation Société anonyme designs and builds military aircraft, business jets, and space systems in France, the Americas, and internationally. It offers Rafale, a multirole fighter aircraft; nEUROn, an unmanned combat air vehicle; and Falcon aircraft for maritime surveillance, intelligence, and medical evacuation missions. The company operates a fleet of 2,100 Falcon jets and 1,000 fighter aircraft. In addition, it provides aviation maintenance and training services; repairs and maintains landing gears and flight controls; overhauls and repairs civil aviation equipment; leases and manages Falcon aircraft as part of public passenger transport activity; and designs, produces, and distributes simulation tools. The company was founded in 1916 and is headquartered in Paris, France. Dassault Aviation Société anonyme is a subsidiary of Groupe Industriel Marcel Dassault S.A.

Revenue Growth

Year-on-year quarterly revenue growth grew by 0.5%, now sitting on 7.27B for the twelve trailing months.

Volume

Today’s last reported volume for DASSAULT AVIATION is 6862 which is 84.35% below its average volume of 43860.

Yearly Top and Bottom Value

DASSAULT AVIATION’s stock is valued at €162.00 at 23:50 EST, under its 52-week high of €168.00 and way above its 52-week low of €112.40.

More news about DASSAULT AVIATION.

3. AURES TECHNOLOGIES (AURS.PA)

Shares of AURES TECHNOLOGIES dropped 5.37% in from €9.05 to €8.56 at 23:50 EST on Wednesday, after three successive sessions in a row of losses. CAC 40 is sliding 0.2% to €7,324.76, following the last session’s downward trend.

AURES Technologies S.A. designs, manufactures, and sells point of sale (POS) systems and terminals, and related peripherals. The company provides all-in-one touch screen terminals, POS systems, and retail solutions; POS and mobile tablets; POS modular solutions; touchscreen panels; POS thermal receipt printers; complementary screens, displays, and monitors; and a range of accessories, such as barcode scanners, specific readers for magnetic cards, biometric readers, and RFID readers. It also offers consulting, staging, installation, decommissioning, asset tracking, real time POS monitoring, and onsite support services. The company offers its products for food and non-food stores, shops, retail outlets, superstores and supermarkets, catering and hospitality businesses, snacking and takeaway outlets, leisure and sport venues, etc. It markets its products through a network of distributors, resellers, agents, and partners in France, the United Kingdom, Germany, Australia, the United States, and internationally. The company was founded in 1989 and is headquartered in Lisses, France.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AURES TECHNOLOGIES’s stock is considered to be overbought (>=80).

Volatility

AURES TECHNOLOGIES’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.65%, a negative 0.60%, and a positive 1.57%.

AURES TECHNOLOGIES’s highest amplitude of average volatility was 1.81% (last week), 1.38% (last month), and 1.57% (last quarter).

Volume

Today’s last reported volume for AURES TECHNOLOGIES is 1251 which is 23.11% below its average volume of 1627.

More news about AURES TECHNOLOGIES.

4. TER BEKE (TERB.BR)

Shares of TER BEKE jumped 6.11% in from €81.8 to €86.80 at 23:50 EST on Wednesday, after five consecutive sessions in a row of gains. BEL 20 is sliding 0.08% to €3,849.32, after two sequential sessions in a row of losses.

Ter Beke NV, together with its subsidiaries, develops, produces, and sells a range of processed meat products and ready meals to discount and retail clients in Europe. It operates through two segments, Processed Meats and Ready Meals. The Processed Meats segment develops, produces, and sells a range of processed meats, including salami, cooked ham, poultry, other cooked meats, pâtés, preserved meats, tongue, and liver products under the Pluma, Daniël Coopman, Zonnenberg, Kraak-Vers, and FairBeleg brand names, as well as other private labels. The Ready Meals segment develops, produces, and sells freshly prepared ready meals including lasagne, pizza, pasta dishes, and sauces under the Come a casa, Vamos, and Stefano Toselli brand names, as well as private labels. Ter Beke NV was founded in 1948 and is based in Gent, Belgium. Ter Beke NV is a subsidiary of Stak Coovan.

Sales Growth

TER BEKE’s sales growth is 6.8% for the ongoing quarter and 6.8% for the next.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, TER BEKE’s stock is considered to be oversold (<=20).

More news about TER BEKE.

5. AVANTIUM (AVTX.AS)

Shares of AVANTIUM dropped 6.19% in from €4.65 to €4.36 at 23:50 EST on Wednesday, following the last session’s downward trend. AEX-Index is rising 0.24% to €753.35, after two successive sessions in a row of losses.

Avantium N.V., a chemical technology company, develops and commercializes renewable chemistry solutions in the Netherlands. The company operates through three segments: Avantium Catalysis, Avantium Renewable Chemistries, and Avantium Renewable Polymers. It offers furandicarboxylic acid, a building block for polyethylene furanoate (PEF); and PEF, a plant-based recyclable plastic for use as packaging material. The company also provides catalyst testing systems, including Flowrence that provides catalyst testing and adsorbents. In addition, the company R&D system, services, and refinery catalyst testing services. Further, it develops ray technology to produce mono-ethylene glycol from industrial sugars; and dawn technology which converts non-food plant-based feedstock to industrial sugars and lignin. Additionally, the company produces polyesters using plantMEG. Avantium N.V. was founded in 2000 and is headquartered in Amsterdam, the Netherlands.

More news about AVANTIUM.

6. MCPHY ENERGY (MCPHY.PA)

Shares of MCPHY ENERGY slid 4.93% in from €13.44 to €12.78 at 23:50 EST on Wednesday, after three sequential sessions in a row of losses. CAC 40 is sliding 0.2% to €7,324.76, following the last session’s downward trend.

McPhy Energy S.A. designs, develops, and supplies hydrogen production, storage, and distribution equipment for hydrogen energy, hydrogen mobility, and industrial hydrogen markets. The company offers alkaline electrolyzers; and hydrogen storage solutions and fuel cells. It also designs hydrogen stations; and provides integrated hydrogen solutions. It operates in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company was incorporated in 2007 and is headquartered in La Motte, France.

Yearly Top and Bottom Value

MCPHY ENERGY’s stock is valued at €12.78 at 23:50 EST, way under its 52-week high of €21.28 and way higher than its 52-week low of €7.55.

Moving Average

MCPHY ENERGY’s worth is below its 50-day moving average of €13.44 and below its 200-day moving average of €12.93.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, MCPHY ENERGY’s stock is considered to be overbought (>=80).

Volatility

MCPHY ENERGY’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.89%, a negative 0.39%, and a positive 2.18%.

MCPHY ENERGY’s highest amplitude of average volatility was 1.01% (last week), 1.55% (last month), and 2.18% (last quarter).

More news about MCPHY ENERGY.

7. MERCIALYS (MERY.PA)

Shares of MERCIALYS rose 0.38% in from €10.5 to €10.54 at 23:50 EST on Wednesday, following the last session’s downward trend. CAC 40 is sliding 0.2% to €7,324.76, following the last session’s downward trend.

Mercialys is one of France's leading real estate companies, focused exclusively on shopping centers and high-street retail assets. At June 30, 2020, Mercialys had a portfolio of 2,111 leases, representing a rental value of Euro 182.3 million on an annualized basis. At June 30, 2020, it owned properties with an estimated value of Euro 3.5 billion (including transfer taxes). Mercialys has had “SIIC” real estate investment trust (REIT) tax status since November 1, 2005 and has been listed on Euronext Paris Compartment A (ticker: MERY) since its initial public offering on October 12, 2005. At June 30, 2020, there were 92,049,169 shares outstanding.

More news about MERCIALYS.

8. CARMILA (CARM.PA)

Shares of CARMILA rose 6.29% in from €13.98 to €14.86 at 23:50 EST on Wednesday, after five sequential sessions in a row of gains. CAC 40 is sliding 0.2% to €7,324.76, following the last session’s downward trend.

The third listed company of shopping centres in Continental Europe, Carmila was created by Carrefour and major institutional investors to transform and enhance the shopping centres adjoining Carrefour stores in France, Spain and Italy. As of 30 June 2020, its portfolio consisted of 215 shopping centres, leaders in their catchment area, valued at 6.2 billion euros. Putting proximity at the heart of all its actions, Carmila aims to simplify life and improve the daily lives of merchants and customers in the heart of all territories. Driven by a true commercial culture, its teams integrate all the expertise dedicated to the attractiveness of its assets: operations, center management, marketing, local digital marketing, new business and CSR. Carmila is listed in Compartment A on Euronext-Paris under the symbol CARM. It benefits from the regime of listed real estate investment companies ("SIIC"). On September 18, 2017, Carmila joined the FTSE EPRA/NAREIT Global Real Estate (EMEA Region) indices. On September 24, 2018, Carmila joined the Euronext CAC Small, CAC Mid Small and CAC All-tradable indices.

Revenue Growth

Year-on-year quarterly revenue growth grew by 5.5%, now sitting on 456.58M for the twelve trailing months.

Volatility

CARMILA’s last week, last month’s, and last quarter’s current intraday variation average was 1.38%, 0.32%, and 1.16%.

CARMILA’s highest amplitude of average volatility was 1.38% (last week), 0.94% (last month), and 1.16% (last quarter).

More news about CARMILA.

9. GUILLEMOT (GUI.PA)

Shares of GUILLEMOT jumped 0.86% in from €9.27 to €9.35 at 23:50 EST on Wednesday, after two successive sessions in a row of losses. CAC 40 is dropping 0.2% to €7,324.76, following the last session’s downward trend.

Guillemot Corporation S.A. designs, manufactures, and sells interactive entertainment hardware and accessories in France, Germany, the United Kingdom, Spain, the United States, Canada, Italy, China, Belgium, and Romania. It offers digital hardware and peripherals under the Hercules brand name; PC and console gaming accessories under the Thrustmaster brand name; and DJ solutions for various connected devices under the DJUCED brand name. Guillemot Corporation S.A. was founded in 1984 and is based in Chantepie, France.

Volume

Today’s last reported volume for GUILLEMOT is 4867 which is 67.21% below its average volume of 14845.

Volatility

GUILLEMOT’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.67%, a negative 0.03%, and a positive 2.17%.

GUILLEMOT’s highest amplitude of average volatility was 1.37% (last week), 2.04% (last month), and 2.17% (last quarter).

More news about GUILLEMOT.

10. ORKLA (ORK.OL)

Shares of ORKLA slid 6.39% in from kr74.95 to kr70.16 at 23:50 EST on Wednesday, after two consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI is dropping 0.14% to kr1,243.59, after two successive sessions in a row of losses.

Orkla ASA engages in branded consumer goods, and industrial and financial investment businesses. The company offers branded products, including frozen pizza, ketchup, soups, sauces, bread toppings, and ready-to-eat meals through grocery retail trade, as well as the out-of-home, convenience store, and petrol station sectors. It also provides confectionery, biscuit, and snack products; and develops crispbread products, as well as energy snack meals. In addition, the company offers personal care and cleaning products; dietary supplement, sport nutrition, and weight control products; wound care products and first aid equipment; painting tools; basic garments; and professional cleaning products. Further, it operates Gymgrossisten and Bodystore e-commerce portals for health and sports nutrition products; and restaurants. Additionally, the company supplies margarine and butter blends, bread and cake improvers and mixes, yeast, marzipan, and ice cream ingredients; produces and supplies hydro power to the Nordic power market; and develops and sells real estate properties. It offers its food products under the Grandiosa, TORO, Stabburet, Felix, Paulúns, Abba, Kalles, Beauvais, Den Gamle Fabrik, Spilva, Vitana, MTR, and Eastern brands; confectionery and snacks under the KiMs, Nidar, Stratos, Göteborgs Kex, Sætre, OLW, Panda, Laima, Selga, Taffel, Adazu, and Kalev brands; health and sports nutrition under Zalo, Jif, Bliw, Grumme, Blenda, Define, Möller's, Collett, Nutrilett, Maxim, Norgesplaster, and Salvequick brands; and food ingredients under Odense, Mors Hjemmebakte, KronJäst, Bakkedal and NATURLI' brands. It has operations in Norway, Sweden, Denmark, Finland, Iceland, the Baltics, rest of Europe, and internationally. The company is headquartered in Oslo, Norway.

Moving Average

ORKLA’s value is below its 50-day moving average of kr72.22 and below its 200-day moving average of kr75.65.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is a negative 12.1% and a negative 14.3%, respectively.

Revenue Growth

Year-on-year quarterly revenue growth grew by 14.6%, now sitting on 58.39B for the twelve trailing months.

More news about ORKLA.

11. MEDINCELL (MEDCL.PA)

Shares of MEDINCELL jumped 0.63% in from €8 to €8.05 at 23:50 EST on Wednesday, following the last session’s upward trend. CAC 40 is dropping 0.2% to €7,324.76, following the last session’s downward trend.

MedinCell S.A. develops various therapeutic solutions in France. It develops solutions based on BEPO, a technology for long-acting injectable products based on proprietary copolymers and a biocompatible solvent, which solubilizes or suspends the active pharmaceutical ingredients. The company's products in development include mdc-IRM, a risperidone extended-release injectable suspension completed Phase III trial for use in the treatment of schizophrenia; mdc-CWM, a sustained-release formulation of celecoxib in Phase III trials for use in the treatment of reduction of postoperative pain & inflammation; and mdc-TJK, a subcutaneous injection in Phase III trials for use in the treatment of schizophrenia. Its product candidates in preclinical trials, such as mdc-ANG, an antipsychotic product for use in the treatment of schizophrenia; mdc-TTG for Covid-19 and its variants; mdc-GRT for use in organ transplant; mdc-WWM for contraception; mdc-STM for use in malaria; mdc-KPT for use in acute pain for pets; and mdc-IRM for use in neuroscience. The company was incorporated in 2003 and is based in Jacou, France.

Yearly Top and Bottom Value

MEDINCELL’s stock is valued at €8.05 at 23:50 EST, way under its 52-week high of €9.09 and way above its 52-week low of €4.73.

More news about MEDINCELL.

12. ALAN ALLMAN (AAA.PA)

Shares of ALAN ALLMAN fell 7.78% in from €9.76 to €9.00 at 23:50 EST on Wednesday, following the last session’s downward trend. CAC 40 is sliding 0.2% to €7,324.76, following the last session’s downward trend.

Alan Allman Associates provides management consulting services. The company provides research and consulting services to other organizations and primarily serves organizations providing consulting services to various sectors. It was founded in 2009 and is based in Issy-les-Moulineaux, France.

Volume

Today’s last reported volume for ALAN ALLMAN is 2049 which is 13.26% above its average volume of 1809.

Volatility

ALAN ALLMAN’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.50%, a negative 0.39%, and a positive 2.31%.

ALAN ALLMAN’s highest amplitude of average volatility was 1.17% (last week), 1.92% (last month), and 2.31% (last quarter).

More news about ALAN ALLMAN.

13. FUGRO (FUR.AS)

Shares of FUGRO slid 4.94% in from €12.36 to €11.75 at 23:50 EST on Wednesday, after two successive sessions in a row of losses. AEX-Index is rising 0.24% to €753.35, after two successive sessions in a row of losses.

Fugro N.V. provides geo-data information through integrated data acquisition, analysis, and advice for infrastructure, energy, and water industries. It offers marine geo-consulting, marine geo-technics, geo-physical survey, metocean surveys, marine environmental, and hydrographic survey services. The company also provides geo-technical ground investigation, geological and geophysical survey, nearshore geotechnical site investigation, testing and monitoring, environmental site characterization and remediation, water consultancy services, and geo consulting services. In addition, it offers positioning and construction support, satellite positioning, monitoring and forecasting, IRM, ROV services and tooling, and marine infrastructure solutions. Further, the company provides digital plant and pipelines, surveying and mapping, raildata, roadware surveys, Roames power, and land weather forecasting services. It serves in Europe, Africa, the Americas, the Asia Pacific, the Middle East, and India. The company was incorporated in 1962 and is headquartered in Leidschendam, the Netherlands.

Moving Average

FUGRO’s value is below its 50-day moving average of €11.88 and under its 200-day moving average of €12.27.

Volume

Today’s last reported volume for FUGRO is 52391 which is 90.69% below its average volume of 563317.

Volatility

FUGRO’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.19%, a negative 0.35%, and a positive 2.14%.

FUGRO’s highest amplitude of average volatility was 1.25% (last week), 1.54% (last month), and 2.14% (last quarter).

More news about FUGRO.

14. TARGOVAX (TRVX.OL)

Shares of TARGOVAX dropped by a staggering 24.36% in from kr1.03 to kr0.78 at 23:50 EST on Wednesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI is falling 0.14% to kr1,243.59, after two sequential sessions in a row of losses.

Targovax ASA, a clinical stage immuno-oncology company, engages in the development of immune activators to target hard-to-treat solid tumors. Its lead product candidate is ONCOS-102, which is in Phase I/II clinical trials for the treatment of mesothelioma, melanoma, and colorectal cancer. The company is also developing neoantigen vaccines targeting mutant KRAS cancers. In addition, it is developing ONCOS-211 for next generation ONCOS viruses. The company has collaboration agreements with Cancer Research Institute and Ludwig Cancer Research to develop ONCOS-102 for colorectal cancer with peritoneal carcinomatosis; Valo Therapeutics to develop mutant RAS neoantigen coating of ONCOS viruses using PeptiCRAd technology; and Papyrus Therapeutics to develop novel ONCOS viruses with Receptor Tyrosine Kinase inhibitor functionality. Targovax ASA was incorporated in 2010 and is based in Lysaker, Norway.

More news about TARGOVAX.

15. INVENTIVA (IVA.PA)

Shares of INVENTIVA dropped by a staggering 30.53% in from €6.51 to €4.52 at 23:50 EST on Wednesday, after five consecutive sessions in a row of losses. CAC 40 is falling 0.2% to €7,324.76, following the last session’s downward trend.

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH. The company also develops Odiparcil, which has completed Phase IIa clinical trial for the treatment of MPS VI subtype disease. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company has strategic collaboration with AbbVie for the treatment of autoimmune diseases; and Boehringer Ingelheim International GmbH for developing new treatments for idiopathic pulmonary fibrosis. Inventiva S.A. was founded in 2011 and is based in Daix, France.

Volume

Today’s last reported volume for INVENTIVA is 4927 which is 74.89% below its average volume of 19626.

More news about INVENTIVA.

16. AIRBUS (AIR.PA)

Shares of AIRBUS rose by a staggering 11.47% in from €112.3 to €125.18 at 23:50 EST on Wednesday, following the last session’s upward trend. CAC 40 is falling 0.2% to €7,324.76, following the last session’s downward trend.

Airbus SE engages in the designing, manufacturing, and delivering aerospace products, services, and solutions worldwide. It operates through three segments: Airbus, Airbus Helicopters, and Airbus Defence and Space. The Airbus segment develops, manufactures, markets, and sells commercial jet aircraft of approximately 100 seats; and regional turboprop aircraft and aircraft components, as well as provides aircraft conversion and related services. The Airbus Helicopters segment engages in the development, manufacturing, marketing, and sale of civil and military helicopters; and provision of helicopter related services. The Airbus Defence and Space segment designs, develops, delivers, and supports military aircraft, such as combat, mission, transport, tanker aircraft, and their associated services; and offers unmanned aerial systems. This segment also offers civil and defense space systems for telecommunications, earth observations, navigation, science, and orbital systems; missile systems; and space launcher systems, as well as services around data processing from platforms, secure communication, and cyber security. The company was formerly known as Airbus Group SE and changed its name to Airbus SE in April 2017. Airbus SE was incorporated in 1998 and is based in Leiden, the Netherlands.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AIRBUS’s stock is considered to be oversold (<=20).

Moving Average

AIRBUS’s value is higher than its 50-day moving average of €115.35 and way above its 200-day moving average of €105.81.

Sales Growth

AIRBUS’s sales growth is 20.2% for the current quarter and 10.8% for the next.

Volume

Today’s last reported volume for AIRBUS is 332849 which is 71.19% below its average volume of 1155400.

More news about AIRBUS.